Zynyz 500 mg/20 mL (25 mg/mL) injection Images
Generic Name: retifanlimab
This medication has been identified as Zynyz 500 mg/20 mL (25 mg/mL) injection and is used for Anal Cancer, and Merkel Cell Carcinoma. It belongs to the drug class anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors) and is not a controlled substance.
Images of medication
Zynyz
- Generic Name
- retifanlimab
- Strength
- 500 mg/20 mL (25 mg/mL) injection
- Availability
- Prescription only
- Drug Class
- Anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Incyte Corporation
- National Drug Code (NDC)
- 50881-0006
See also:
More about Zynyz (retifanlimab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.